All In Biotech

Drug Trial Radar · NCT07085468

A Study of LY3549492 in Healthy Weight Adult Participants

A Parallel-Group, Double-Blind Study to Investigate the Safety and Tolerability of LY3549492 Compared With Placebo in Adult Participants Aged 55 to 80 Years With a BMI of 22 to 25 kg/m2

Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

1

Actual

Start

Jul 21, 2025

Primary completion

Aug 14, 2025

Study completion Aug 14, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.

Conditions

  • Healthy

Interventions

  • LY3549492Drug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With One or More Serious Adverse Events (SAE) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline through Week 48

Locations

21 sites in 2 countries. Site status is shown where the registry gives one.

  • Headlands Research - Scottsdale

    Scottsdale, Arizona

  • Valley Clinical Trials, Inc.

    Covina, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Peninsula Research Associates

    Rolling Hills Estates, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • JEM Research Institute

    Atlantis, Florida

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Great Lakes Clinical Trials - Andersonville

    Chicago, Illinois

  • Alliance for Multispecialty Research, LLC

    Lexington, Kentucky

  • Alliance for Multispecialty Research, LLC

    Norman, Oklahoma

  • Trial Management Associates

    Myrtle Beach, South Carolina

  • Viacar Recherche Clinique

    Greenfield Park, Canada

  • Apex Trials

    Guelph, Canada

  • OCT Research ULC

    Kelowna, Canada

  • Clinique Mémoire de Montréal

    Montreal, Canada

  • Ottawa Memory Clinic

    Ottawa, Canada

  • Richmond Clinical Trials

    Richmond, Canada

  • Q&T Research Sherbrooke Inc.

    Sherbrooke, Canada

  • Toronto Memory Program

    Toronto, Canada

  • BioPharma Services

    Toronto, Canada

  • Diex Recherche Trois-Rivieres

    Trois-Rivières, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.